Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ARMP
$4.56
-5.39%
ARMP · Armata Pharmaceuticals, Inc.
$4.56
-0.26 (-5.39%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within our control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Market Cap
$169.55M
Shares
37.18M
All earnings calls
Earnings call · FY2025 Q3
Armata Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Armata Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$0.74
Net income
-$26.68M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 12, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 12, 2025 · complete as-filed document